Skip to search.
 BSE Up0.15% NSE Up0.28%

More On ANKURDRUG.NS

Quotes

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Ankur Drugs & Pharma Ltd. (ANKURDRUG.NS)

-NSE

11.50 Down 0.40(3.36%) 28 Jan 3:31PM

Add to Portfolio
Key StatisticsGet Key Statistics for:
Data provided by Capital IQ, except where noted.
Valuation Measures 
Market Cap (intraday)5:N/A
Enterprise Value (25-May-2013)3:7.15B
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye 31-Mar-2014)1:N/A
PEG Ratio (5 yr expected)1:N/A
Price/Sales (ttm):N/A
Price/Book (mrq):N/A
Enterprise Value/Revenue (ttm)3:5.06
Enterprise Value/EBITDA (ttm)6:-149.38
Financial Highlights 
Fiscal Year
Fiscal Year Ends:31 Mar
Most Recent Quarter (mrq):31-Dec-2012
Profitability
Profit Margin (ttm):-235.92%
Operating Margin (ttm):-52.91%
Management Effectiveness
Return on Assets (ttm):N/A
Return on Equity (ttm):N/A
Income Statement
Revenue (ttm):1.41B
Revenue Per Share (ttm):73.04
Qtrly Revenue Growth (yoy):-6.10%
Gross Profit (ttm):2.31B
EBITDA (ttm)6:-47.84M
Net Income Avl to Common (ttm):-3.33B
Diluted EPS (ttm):N/A
Qtrly Earnings Growth (yoy):N/A
Balance Sheet
Total Cash (mrq):20.80M
Total Cash Per Share (mrq):1.08
Total Debt (mrq):7.01B
Total Debt/Equity (mrq):463.23
Current Ratio (mrq):N/A
Book Value Per Share (mrq):0.00
Cash Flow Statement
Operating Cash Flow (ttm):N/A
Levered Free Cash Flow (ttm):N/A
View Financials
Income Statement - Balance Sheet - Cash Flow
Trading Information 
Stock Price History
Beta:N/A
52-Week Change3:-35.34%
S&P500 52-Week Change3:12.95%
52-Week High (06-Jul-2012)3:20.45
52-Week Low (21-Mar-2013)3:6.40
50-Day Moving Average3:7.81
200-Day Moving Average3:10.41
Share Statistics
Avg Vol (3 month)3:10,628
Avg Vol (10 day)3:11,551
Shares Outstanding5:NaN
Float:15.51M
% Held by Insiders1:N/A
% Held by Institutions1:N/A
Shares Short 3:N/A
Short Ratio 3:N/A
Short % of Float 3:N/A
Shares Short (prior month)3:N/A
Dividends & Splits
Forward Annual Dividend Rate4:N/A
Forward Annual Dividend Yield4:N/A
Trailing Annual Dividend Yield3:N/A
Trailing Annual Dividend Yield3:N/A
5 Year Average Dividend Yield4:N/A
Payout Ratio4:N/A
Dividend Date3:N/A
Ex-Dividend Date4:N/A
Last Split Factor (new per old)2:N/A
Last Split Date3:N/A

See Key Statistics Help for definitions of terms used.
Abbreviation Guide: K = Thousands; M = Millions; B = Billions
mrq = Most Recent Quarter (as of 31-Dec-2012)
ttm = Trailing Twelve Months (as of 31-Dec-2012)
yoy = Year Over Year (as of 31-Dec-2012)
lfy = Last Fiscal Year (as of 31-Mar-2012)
fye = Fiscal Year Ending
1 Data provided by Thomson Reuters
2 Data provided by EDGAR Online
3 Data derived from multiple sources or calculated by Yahoo! Finance
4 Data provided by Morningstar, Inc.
5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

Currency in INR.